Biohaven Ltd. BHVN

Updated: 14 Jun 2026

NYSE | Biotech | Biopharmaceutical research and development

No signal published yet

We already track Biohaven and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Biohaven free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Type
Biotech
Sector
Biopharmaceutical research and development
We're already tracking Biohaven Ltd. — here are the latest events we've registered

Recent News

  • On June 1, 2026, Biohaven announced the first-in-human dosing of BHV-8100, an oral PKM2 modulator. In May 2026, the company reported positive clinical biomarker data for its protein degrader candidates BHV-1300 and BHV-1400. Topline results for its pivotal epilepsy and obesity programs are expected in the second half of 2026.

What Firelda Watch includes for Biohaven Ltd.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Biohaven Ltd. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Recipharm
RECI B
NEUTRAL
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD

Biotech

More companies in this sector

Want to follow Biohaven Ltd.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Biohaven free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Biohaven Ltd. BHVN
Biohaven — follow and we'll monitor it
Follow Biohaven free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.